Catalyst
Slingshot members are tracking this event:
First-Line Lung Cancer Data and Other New Research from Merck’s Broad Oncology Program to be Presented at AACR Annual Meeting
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MRK |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 16, 2018
Occurred Source:
http://www.mrknewsroom.com/news-release/oncology/mercks-keytruda-pembrolizumab-plus-pemetrexed-alimta-and-platinum-chemotherapy
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Keytruda, Lung Cancer, Oncolytic Immunotherapy, Nsclc
